Fabre-Kramer Pharmaceuticals, Inc.

The company was formed to identify, develop and commercialize psychotropic drugs with significant market potential.

Founded 1992

Houston, United States 8 employees Health Care, Pharmaceutical

Fabre-Kramer Pharmaceuticals, Inc. is a pharmaceutical company based in the United States, founded in 1992. The company specializes in identifying, developing, and commercializing psychotropic drugs with significant market potential. With over 40 years of experience in the clinical development of psychotropic drugs, Fabre-Kramer Pharmaceuticals has conducted pivotal studies in various psychiatric disorders including depression, anxiety, schizophrenia, bipolar disorder, social phobia, and sleep disorders. The company's expertise extends to in-patient and out-patient psychiatry, providing them with intimate knowledge of Central Nervous System disorders. At Fabre-Kramer Pharmaceuticals, the focus lies on developing and introducing advanced medications to address unmet medical needs. The company aims to identify and acquire promising psychotropic drugs from major pharmaceutical companies and other industry and academic sources. With a strong emphasis on receptor activity, efficacy, tolerability, side effect/benefit ratio, formulation, ease of administration, cost, and ease of manufacturing, Fabre-Kramer Pharmaceuticals is well-positioned to bring innovative medications to market. As a venture capital analyst, this pharmaceutical company presents a compelling opportunity due to its extensive experience, clear focus on a specific niche within the healthcare and pharmaceutical industries, and the potential for addressing unmet medical needs. With a solid track record and a focus on innovation, Fabre-Kramer Pharmaceuticals could be an attractive investment prospect for venture capitalists seeking opportunities in the pharmaceutical sector.

FAQ About Fabre-Kramer Pharmaceuticals, Inc.

The company was formed to identify, develop and commercialize psychotropic drugs with significant market potential.

Fabre-Kramer Pharmaceuticals, Inc. was founded in 1992.

Fabre-Kramer Pharmaceuticals, Inc. is headquartered in Houston, United States.

Fabre-Kramer Pharmaceuticals, Inc. operates in Health Care and Pharmaceutical. Its work centres on pharmaceuticals, psychotropic drugs, clinical development and FDA approval.

Fabre-Kramer Pharmaceuticals, Inc. has approximately 8 employees.

Top alternatives and competitors to Fabre-Kramer Pharmaceuticals, Inc. include IXALTIS SA, Reviva Pharmaceuticals, Acadia Pharmaceuticals, Emyria (ASX:EMD), Courage Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Fabre-Kramer Pharmaceuticals, Inc. and IXALTIS SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Fabre-Kramer Pharmaceuticals, Inc.

General Information

Discover More

About Fabre-Kramer Pharmaceuticals, Inc.

Fabre-Kramer Pharmaceuticals, Inc. Alternatives & Competitors

FAQ About Fabre-Kramer Pharmaceuticals, Inc.